| Autor: |
Barnes, Kylie N., Leader, Lauren D., Cieri-Hutcherson, Nicole E., Kelsey, Julie, Hebert, Mary F., Karaoui, Lamis R., McBane, Sarah |
| Předmět: |
|
| Zdroj: |
Journal of Pharmacy Practice; Apr2024, Vol. 37 Issue 2, p467-477, 11p |
| Abstrakt: |
Complications throughout the peripartum period may be caused by preexisting conditions or pregnancy-induced conditions and may alter pharmacotherapy management. Pharmacotherapy management during late pregnancy and delivery requires careful consideration due to changing hormones, hemodynamic status, and pharmacokinetics, and concerns for potential maternal and/or fetal morbidity. Increased maternal and fetal monitoring are often required and may lead to therapy changes. Pharmacists, as key members of the interprofessional team, can contribute essential perspective to the management of postpartum pharmacotherapy through assessment and recommendation of appropriate and judicious use of medications. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
